Programme

Tentative program

 

THURSDAY 27 NOVEMBER

 

12.00-13.00 Registration + poster set up + coffee

 

13.00-13.30 Welcome address Gustaf Ljungman, Johanna Sandgren

The Swedish Childhood Tumor Biobank

Invited dignitaries

 

13.35-14.10 Globalizing Access to State-of-the-Art Molecular Tumor Diagnostics – Stefan Pfister

14.15-14.50 Childhood cancer biobanks

The Norwegian Childhood Cancer Biobank, TBA Lars Baumbusch  

The Latvian Pediatric Cancer Biobank, TBA Representative

 

14.55-15.30 Large scale biomedical initiatives and resources for precision medicine

U-CAN, Biobank Sverige, TBA Tobias Sjöblom

Precision Omics Initiative Sweden (PROMISE), TBA Tuuli Lappalainen

15.30-16.00 Coffee and poster exhibition

 

16.00-16.35 Access to targeted therapies, TBA     

                    

16.40-17.15 Innovative Therapies for Children and adolescents with Cancer – ITCC, TBA

Open studies in the Nordic countries, TBA

Access to targeted therapies in Sweden, TBA

 

16.50-17.25 Liquid biopsies in pediatric cancer 

Liquid biopsies for CNS-tumors, TBA Emma Tham

Liquid biopsies for extracranial solid tumors, TBA Martin Dalin

17.25-17.50 Rapid Fire Poster presentation

 

17.50-18.45 Poster exhibition and networking

 

19.00-21.00 Dinner at Haga Bottega 

 

FRIDAY 28 NOVEMBER

 

08.30-09.05 Application of novel diagnostic methodology and AI in pediatric brain tumors, TBA Felix Sahm

09.10-09.45 Impact of developments in pathology and immunology for pediatric  cancer patients       

Tumor cell evolution/heterogeneity, TBA David Gisselsson Nord

Immunological understanding for the development of novel therapies, TBA Petter Brodin

09.50- 10.25 New diagnostics and integration of health data for research and clinical value

Potentials of radiology and pathology images and AI in pediatric brain tumor diagnostics Neda Haj-Hosseini

Genomic Medicine Sweden Childhood Cancer and Brainchild David Gisselsson Nord

10.25-10.55 Coffee and poster exhibition

 

10.55-11.30 Pediatric Cancer Predisposition

Childhood Cancer Predisposition – ChiCaP Ann Nordgren

TP53 cancer predisposition syndrom, TBA  Svetlana Lagerkrantz

11.35-12.10 Oncolytic viruses for immune therapy in children, TBA Martha Alonso

12.10-13.00 Lunch and poster exhibition

 

13.00-13.35 Resistance mechanisms for different therapies, TBA  Pratiti Bandopadhayay

13.40-14.15 Application of functional precision medicine in cancer

Importance and prerequisites for precision medicine, TBA Pävi Östling

Models for testing novel treatments in childhood cancer Fredrik Swartling

14.20-14.55 Selected presentations from submitted abstracts/posters (2)

14.55-15.20 Coffee and poster exhibition

 

15.20-15.55 Next generation precision medicine for childhood tumors -Mathias Uhlen

16.00-16.15 Concluding remarks and best poster awards